Cargando…

Bone Mineral Density in Different Menopause Stages is Associated with Follicle Stimulating Hormone Levels in Healthy Women

Although estradiol (E(2)) has been believed to be the most critical factor in the menopause-associated decrease in bone mineral density (BMD), the role of increasing follicle stimulating hormone (FSH) during menopause is relatively unclear. We determined the extent to which hip and lumbar spine BMD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Young-Min, Jankowski, Catherine M., Swanson, Christine M., Hildreth, Kerry L., Kohrt, Wendy M., Moreau, Kerrie L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908273/ https://www.ncbi.nlm.nih.gov/pubmed/33572819 http://dx.doi.org/10.3390/ijerph18031200

Ejemplares similares

A relative L‐arginine deficiency contributes to endothelial dysfunction across the stages of the menopausal transition
por: Klawitter, Jelena, et al.
Publicado: (2017)

Vascular Aging across the Menopause Transition in Healthy Women
por: Moreau, Kerrie L., et al.
Publicado: (2014)

Association of follicle‐stimulating hormone with bone turnover markers and bone mineral density in Chinese women across the menopausal transition
por: Li, Lin, et al.
Publicado: (2023)

Timing of Ibuprofen Use and Bone Mineral Density Adaptations to Exercise Training
por: Kohrt, Wendy M, et al.
Publicado: (2010)

Effects of follicle-stimulating hormone on fat metabolism and cognitive impairment in women during menopause
por: Mao, Liwei, et al.
Publicado: (2022)

Follicle-stimulating hormone and blood lead levels with bone mineral density and the risk of fractures in pre- and postmenopausal women
por: Tong, Huixin, et al.
Publicado: (2022)

Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin
por: Requena, Antonio, et al.
Publicado: (2014)

Associations of Serum Follicle-Stimulating Hormone and Luteinizing Hormone Levels with Fat and Lean Mass during Menopausal Transition
por: Liu, Xun, et al.
Publicado: (2022)

Serum Follicle-Stimulating Hormone Levels are Associated with Cardiometabolic Risk Factors in Post-Menopausal Korean Women
por: Jung, Eun-Soo, et al.
Publicado: (2020)

Associations of follicle-stimulating hormone and luteinizing hormone with metabolic syndrome during the menopausal transition from the National Health and Nutrition Examination Survey
por: Chen, Yongjie, et al.
Publicado: (2023)

Profile of follicle-stimulating hormone and polymorphism of follicle-stimulating hormone receptor in Madrasin cattle with ovarian hypofunction
por: Utomo, Budi, et al.
Publicado: (2020)

The Menopausal Transition: Is the Hair Follicle “Going through Menopause”?
por: Rinaldi, Fabio, et al.
Publicado: (2023)

High Circulating Follicle-Stimulating Hormone Level Is a Potential Risk Factor for Renal Dysfunction in Post-Menopausal Women
por: Li, Qihang, et al.
Publicado: (2021)

The relationship between breast density and bone mineral density after menopause
por: Cho, Jae-Hwan, et al.
Publicado: (2015)

Role of Follicle-Stimulating Hormone in Spermatogenesis
por: Oduwole, Olayiwola O., et al.
Publicado: (2018)

Exercise and Bone Mineral Density in Premenopausal Women: A Meta-Analysis of Randomized Controlled Trials
por: Kelley, George A., et al.
Publicado: (2013)

Hormonal Regulation of Follicle-Stimulating Hormone Glycosylation in Males
por: Campo, Stella, et al.
Publicado: (2019)

Erratum to “Exercise and Bone Mineral Density in Premenopausal Women: A Meta-Analysis of Randomized Controlled Trials”
por: Kelley, George A., et al.
Publicado: (2013)

Isolated follicle stimulated hormone deficiency in male: case report
por: Ratnayake, Gowri M., et al.
Publicado: (2018)

Analysis of the Relationship between Estradiol and Follicle-Stimulating Hormone Concentrations and Polymorphisms of Apolipoprotein E and LeptinGenes in Women Post-Menopause
por: Rył, Aleksandra, et al.
Publicado: (2016)

Corrigendum: High Circulating Follicle-Stimulating Hormone Level Is a Potential Risk Factor for Renal Dysfunction in Post-Menopausal Women
por: Li, Qihang, et al.
Publicado: (2021)

Consecutive versus concomitant follicle-stimulating hormone and highly purified human menopausal gonadotropin: A milder response but better quality
por: Maghraby, Hassan Ali, et al.
Publicado: (2022)

PHYSICOCHEMICAL CHARACTERIZATION OF PITUITARY FOLLICLE-STIMULATING HORMONE
por: Li, Choh Hao, et al.
Publicado: (1952)

Reliability of follicle-stimulating hormone measurements in serum
por: Arslan, Alan A, et al.
Publicado: (2003)

Editorial: Follicle-Stimulating Hormone: Fertility and Beyond
por: Simoni, Manuela, et al.
Publicado: (2019)

FGDB: Database of follicle stimulating hormone glycans
por: Shakyawar, Sushil K, et al.
Publicado: (2021)

Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation
por: Levi Setti, P. E., et al.
Publicado: (2014)

Musashi as a Regulator of the Follicle-Stimulating Hormone in the Gonadotropes
por: Silva Moreira, Ana Rita, et al.
Publicado: (2021)

A Case of Suspected Isolated Follicle-Stimulating Hormone (FSH) Deficiency Where Spermatogenesis Was Acquired by Human Menopausal Gonadotropin (hMG)
por: Sugie, Miho, et al.
Publicado: (2023)

OR13-4 Bone Mineral Density in Transgender Youth on Gender Affirming Therapies
por: Ma, Nina, et al.
Publicado: (2022)

Bone mineral density in midlife long-term users of hormonal contraception in South Africa: relationship with obesity and menopausal status
por: Beksinska, Mags E., et al.
Publicado: (2018)

Effects of Adding Intravenous Pamidronate to Ongoing Menopausal Hormone Therapy in Postmenopausal Korean Women with Low Bone Mineral Density
por: Koo, Young-Ah, et al.
Publicado: (2019)

Follicle-stimulating hormone responsiveness in antral follicles from aryl hydrocarbon receptor knockout mice
por: Hernández-Ochoa, Isabel, et al.
Publicado: (2013)

Small Molecule Follicle-Stimulating Hormone Receptor Agonists and Antagonists
por: Anderson, Ross C., et al.
Publicado: (2019)

Association between Obesity and Bone Mineral Density by Gender and Menopausal Status
por: Salamat, Mohammad Reza, et al.
Publicado: (2016)

Bone Mineral Density and Body Composition are Associated with Circulating Angiogenic Factors in Post-menopausal Women
por: Spangenberg, A., et al.
Publicado: (2016)

SAT399 Are Gender-affirming Hormone Therapy Duration And Body Mass Index Associated With Bone Mineral Density In Transgender And Gender Diverse Adults?
por: Iwamoto, Sean J, et al.
Publicado: (2023)

Discrepancies between Antimullerian Hormone and Follicle Stimulating Hormone in Assisted Reproduction
por: Hussain, Munawar, et al.
Publicado: (2013)

Follicular expression of follicle stimulating hormone receptor variants in the ewe
por: Sullivan, Rachael R, et al.
Publicado: (2013)

A Comparison of Outcomes from In Vitro Fertilization Cycles Stimulated with Follicle Stimulating Hormone Plus either Recombinant Luteinizing Hormone or Human Menopausal Gonadotropins in Subjects Treated with Long Gonadotropin Releasing Hormone Agonist Protocols
por: Bleau, Nathalie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_oucu6dhgm0cgr3k11u7s1ee9l5